Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus (Q87152428)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

6 March 2020

main subject

1 reference

Tamar R Aprahamian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ramon G Bonegio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Zachary Weitzner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Raffi Gharakhanian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ian R Rifkin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

1 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

363-373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456224%20AND%20SRC:MED&resulttype=core&format=json

The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin

6 March 2020

cites work

1 reference

12 December 2020

Emerging roles of PPARs in inflammation and immunity

1 reference

12 December 2020

A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice

1 reference

12 December 2020

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

1 reference

12 December 2020

Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease

1 reference

12 December 2020

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

1 reference

12 December 2020

SLE and metabolic syndrome

1 reference

12 December 2020

Challenges in bringing the bench to bedside in drug development for SLE.

1 reference

12 December 2020

Systemic lupus erythematosus

1 reference

12 December 2020

Premature atherosclerosis in systemic lupus erythematosus

1 reference

12 December 2020

High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors

1 reference

12 December 2020

Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus

1 reference

12 December 2020

Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort

1 reference

12 December 2020

The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus.

1 reference

12 December 2020

Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial.

1 reference

12 December 2020

Functional and structural changes in the kidney in the early stages of obesity

1 reference

12 December 2020

Taming lupus-a new understanding of pathogenesis is leading to clinical advances

1 reference

12 December 2020

Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists

1 reference

12 December 2020

Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake

1 reference

12 December 2020

Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes

1 reference

12 December 2020

Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients.

1 reference

12 December 2020

Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency

1 reference

12 December 2020

Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus

1 reference

12 December 2020

The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus

1 reference

12 December 2020

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

1 reference

12 December 2020

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

1 reference

12 December 2020

Accelerated atherosclerosis in patients with SLE--mechanisms and management

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease

1 reference

12 December 2020

Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation

1 reference

12 December 2020

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

12 December 2020

High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production

1 reference

12 December 2020